Biopharma News : Biopharma and Pharma news from all around the world :
- Crown Bioscience Recognized Once Again as T+ Employer® for the Third Year in a Row
- GE HealthCare Accelerates AI Innovation with Healthcare-Specific Foundation Models Powered by NVIDIA
- Cadence and NVIDIA Unveil Groundbreaking Generative AI and Accelerated Compute-Driven Innovations
- KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference
- Neurogene Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Updates
- DNAnexus to Showcase the Power of High-Value Multi-Omics Data at the Precision Medicine in IBD Summit
- Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update
- Alpine Immune Sciences Provides Corporate Update and Full Year 2023 Financial Results
- PURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results
- Immunis Chairman Dr. Hans Keirstead to Present Abundance360 Moonshot
- Nexus Pharmaceuticals Launches Baclofen Injection, USP
- Global Laboratory Glassware Washers Market Outlook & Forecast 2023-2028: A Shift from Manual to Automation in Laboratories – ResearchAndMarkets.com
- New Research Shows the PrecivityAD2™ Blood Test Has High Accuracy Compared to Amyloid PET Scans in Individuals with Cognitive Impairment
- Global Ventilators Market Focused Insights and Outlook 2024-2029 – KoninKlijke Philips, Hamilton Medical, Resmed, Medtronic & GE Healthcare Lead the Market – ResearchAndMarkets.com
- SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility in Wilson, North Carolina
- US Biosimilar Industry Projected to Surge With CAGR of 40% Through 2028: New Study Highlights Market Growth and Trends – ResearchAndMarkets.com
- Global Markets for Emerging Insulin Drug and Delivery Technologies, with Focus on Syringes and Vials – ResearchAndMarkets.com
- Kindeva Drug Delivery Welcomes Jennifer Riter, New Vice President of Analytical Services
- Bristol Myers Squibb Completes Acquisition of PureTech’s Founded Entity Karuna Therapeutics for $14 Billion
- RxLightning and KnippeRx Partner to Streamline Provider Experience and Accelerate Patient Access to Specialty Medications
- Global Liquid Biopsy Market Forecast Reveals a 15.2% CAGR Growth Through 2035 Amid Rising Demand for Non Invasive Cancer Diagnostics – ResearchAndMarkets.com
- Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
- Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics, Strengthening Neuroscience Portfolio
- Neupulse Secures Funding to Advance World’s First Wearable Device to Tackle Tourettes Syndrome
- Eureka Therapeutics Advances ARYA-3 Clinical Trial to Phase II for Treatment of Liver Cancer Using GPC3-Targeting ARTEMIS® T-cell Therapy
- Otsuka and Lundbeck Present New Data Analyses on the Efficacy of REXULTI® (brexpiprazole) for Agitation Associated with Dementia Due to Alzheimer’s Disease
- seqWell Launches First Assay-ready, 384-well Library Preparation Kit to Enable Ultra-high Throughput Plasmid and Synthetic Construct Sequencing
- Inocras Inc. Unveils Rebranding of Genome Insight
- AliveGen Announces Successful Completion of Phase 1b Multiple-Ascending Dose Clinical Trial for ALG-801
- bluebird bio Secures up to $175 Million Debt Financing with Hercules Capital
News about Biotech, Pharma, Biopharma, Medical Devices, Diagnostics, Digital Health
- Medios acquires Dutch market leader in pharmaceutical compounding services
- Medios acquires Dutch market leader in pharmaceutical compounding services
- SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility
- aap Implantate AG: Capital increase from authorized capital with exclusion of subscription rights
- Mainz Biomed: Webinar on Early Detection of Colorectal Cancer – Exploring New Laboratory Diagnostic Options
- Formycon and Fresenius Kabi reach settlement agreement for ustekinumab biosimilar candidate FYB202 in Europe and Canada
- Heidelberg Pharma announces progress into Cohort 6 with its proprietary ATAC candidate HDP-101 in Phase I/IIa multiple myeloma study
- Newron announces agreement with the European Investment Bank (EIB) to extend the near-term tranche repayment dates of its 2018 financing agreement
- Newron enters into an agreement for the subscription of up to 2.05 million newly issued shares; Proceeds of up to EUR 15.0 million
- Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda
- Beverages made from vine leaves: Sustainable drinking pleasure based on agricultural side streams
- Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business
- Epigenomics AG publishes financial results for fiscal year 2023
- MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
- Medacta Group SA: Medacta Group SA reports robust revenue growth of 19.5% at constant currency and adjusted EBITDA1 margin 26.3%, or 27.9% at constant currency in FY 2023
- Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
- Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG
- Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations
- TRYP THERAPEUTICS ANNOUNCES 99.92% VOTES CAST BY SHAREHOLDERS IN FAVOR OF ARRANGEMENT AGREEMENT AT ANNUAL GENERAL AND SPECIAL MEETING OF SECURITYHOLDERS, AND RECEIPT OF FINAL ORDER
- PolyPeptide with record revenue growth of 43% in H2 2023 versus H1 2023; operational improvements yielding increased profitability and cash flow
- AEVIS VICTORIA SA – Fabrice Zumbrunnen to become CEO of AEVIS VICTORIA SA as of May 1, 2024
- Medartis increases sales by 21% (CER) and improves its underlying EBITDA margin to 16%
- FYB201/Ranibizumab keeps gaining momentum with approvals and launches in the MENA region
- Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update
- Invitation to MorphoSys’ Full Year Results 2023 Conference Call on March 14, 2024
- Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and profit in fiscal year 2023 and pays significantly higher dividend
- Evolva Holding SA in liquidation: Nice & Green requests 3 agenda items be included in AGM agenda
- Heidelberg Pharma to Present First Efficacy Data on HDP-101 and Data from Proprietary ADC Technology Platform at AACR Meeting 2024
- Evotec and Claris Ventures streamline access to accelerate programmes from Claris’s portfolio companies into the clinic
- aap proposes to the bondholders of the mandatory convertible bond 2023/2028 an amendment to the bond terms and conditions to enable the bondholders to exercise their conversion rights earlier
- Madrigal Pharmaceuticals Announces Pricing of Upsized $600 Million Public Offering
- Merit Medical Systems to Announce First Quarter 2024 Results on April 30, 2024
- Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million
- QDOSE® Platform Partnership for Personalized Dosimetry in Radiopharmaceutical Therapy
- Arvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
- Arvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
- Homology Medicines Declares Distribution to Common Stockholders
- Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024
- Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
- Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates
- TaiMed Biologics and AcedrA BioPharmaceuticals Partner to Commercialize Trogarzo® (Ibalizumab-uiyk) in the Middle East and North Africa Region
- Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum
- RS BioTherapeutics Selected for Presentation at American Thoracic Society’s 2024 Respiratory Innovation Summit
- Novonesis will host a conference call regarding 2024 outlook and 2023 pro forma financials on March 21
- Inside Information: Additional Positive Data from the Phase 1 Part of the BEXMAB Study in Both Higher-Risk HMA-Failed MDS and r/r AML
- T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel
- Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in Canada
- Cortexa Leads the World in First Supply of Psilocybin Under the TGA’s Authorized Prescriber Scheme
- Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
- OBI Pharma Announces Poster Presentations at the AACR 2024 Annual Meeting for OBI-992 and GlycOBI™ ADC platform
- SENISCA secures additional £3.7 million financing to support rapid development of senotherapeutic platform to treat age-related disease
- ONWARD® Medical Successfully Completes Benchmark Testing on Path to Commercialize ARC-EX® System
- Valneva Announces Extension of the Interest-Only Period of Its Debt Facility with Deerfield and OrbiMed
- Idorsia and Viatris successfully close the transaction for the global research and development collaboration
- Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
- Financière de Tubize – Annual report 2023
- ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call
- Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics
- Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares
- NurExone’s Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites for more info.
Biopharma News – Pharma News